TUBEROUS SCLEROSIS COMPLEX (TSC)
Clinical trials for TUBEROUS SCLEROSIS COMPLEX (TSC) explained in plain language.
Never miss a new study
Get alerted when new TUBEROUS SCLEROSIS COMPLEX (TSC) trials appear
Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX (TSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame seizures in rare brain disorders
Disease control Not yet recruitingThis early-stage trial tests an oral drug called SVG103 (paxalisib) in 15 adults with rare brain conditions (FCD-II, TSC, or HME) that cause hard-to-control seizures. The main goal is to see if the drug is safe and tolerable, with a secondary look at whether it reduces seizure fr…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Phase: PHASE1, PHASE2 • Sponsor: Sovargen • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Rare kidney disease patients face hidden gum risks
Knowledge-focused Not yet recruitingThis study looks at how common and severe gum disease is in people with rare kidney disorders like Alport syndrome, Fabry disease, and tuberous sclerosis, as well as lupus. Researchers will compare them to people with chronic kidney disease and healthy volunteers. Participants ge…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Sponsor: Stefan Lujinschi • Aim: Knowledge-focused
Last updated May 17, 2026 05:26 UTC